Knollwood Investment Advisory’s Genmab GMAB Stock Holding History

Knollwood Investment Advisory’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+7,300	New	+$194K	0.02%	264
2026 Q1	–	Sell	-7,300	Closed	-$225K	–	310
2025 Q4	$225K	Hold	7,300	–	–	0.02%	312
2025 Q3	$224K	Buy	+7,300	New	+$178K	0.02%	338
2024 Q2	–	Sell	-7,300	Closed	-$218K	–	351
2024 Q1	$218K	Hold	7,300	–	–	0.04%	200
2023 Q4	$232K	Buy	+7,300	New	+$229K	0.05%	196

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Knollwood Investment Advisory's GMAB Position: Q2 2026 in Review

Knollwood Investment Advisory opened a new position in Genmab (GMAB) in Q2 2026: 7,300 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #264 among its holdings. This is a return to the name: Knollwood Investment Advisory previously reported a position in GMAB as recently as Q4 2025.

Knollwood Investment Advisory first reported a position in GMAB in Q4 2023 and has held it in 5 quarters since. The position peaked at $232K in Q4 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

Knollwood Investment Advisory held 7,300 shares of Genmab worth $201K as of Q2 2026.
Genmab was a new Knollwood Investment Advisory position in Q2 2026.
Genmab made up 0.02% of Knollwood Investment Advisory's portfolio in Q2 2026, its #264 holding.
Knollwood Investment Advisory first reported a position in Genmab in Q4 2023 and has held it in 5 quarters since.
Knollwood Investment Advisory's Genmab position peaked at $232K in Q4 2023.
291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Knollwood Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.